1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cost-effectiveness, incompleteness and discrimination
(
- Contribution to journal › Article
- 2021
-
Mark
Is mass screening for coeliac disease a wise use of resources? A health economic evaluation
(
- Contribution to journal › Article
-
Mark
Annual dementia incidence and monetary burden attributable to fine particulate matter (PM2.5) exposure in Sweden
(
- Contribution to journal › Article
- 2018
-
Mark
Cost-effectiveness of supported employment adapted for people with affective disorders
(
- Contribution to journal › Article
- 2015
-
Mark
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
Willingness to Pay and QALYs: What Can We Learn about Valuing Foodborne Risk?
(
- Contribution to journal › Article
- 2014
-
Mark
Prescribed physical activity. A health economic analysis.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Obesity and Surgical Treatment - A Cost-Effectiveness Assessment for Sweden
(
- Contribution to journal › Article
- 2008
-
Mark
PSA-based screening for prostate cancer: How does it compare with other cancer screening tests?
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Comparison of the cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in the United Kingdom based on two different clinical trials
(
- Contribution to journal › Article